Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green.

NCT ID: NCT00376857

Last Updated: 2006-09-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It was the aim of the present study to prospectively compare the functional and morphological outcome of idiopathic epiretinal membrane surgery with and without the assistance of Indocyanine green (ICG). The main outcome measure was improvement of best-corrected visual acuity (BCVA). This was treated as an open question and we had no hypothesis which of the two therapies was superior.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Idiopathic Epiretinal Membrane, Cataract

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Indocyanine green, toxicity, epiretinal membrane, visual field defect

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgery with and without the aid of Indocyanine Green (ICG)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with IEM and cataract or posterior chamber intraocular lens pseudophakia complaining of loss of visual acuity and metamorphopsia during the past six months.

Exclusion Criteria

* Other retinal disease, non-idiopathic epiretinal membrane, glaucoma or history of retinal detachment.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Regensburg

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jost Hillenkamp, MD

Role: PRINCIPAL_INVESTIGATOR

Dept. of Ophthalmology, University of Regensburg

Parykshit Saikia, MD

Role: PRINCIPAL_INVESTIGATOR

Dept. of Ophthalmology, University of Regensburg

Helmut G Sachs, MD

Role: STUDY_CHAIR

Dept. of Ophthalmology, University of Regensburg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept. of Ophthalmology, University of Regensburg

Regensburg, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Hillenkamp J, Saikia P, Herrmann WA, Framme C, Gabel VP, Sachs HG. Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: a randomised controlled clinical trial. Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):973-9. doi: 10.1007/s00417-006-0485-1. Epub 2006 Dec 21.

Reference Type DERIVED
PMID: 17186261 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

03123

Identifier Type: -

Identifier Source: org_study_id